These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37027328)

  • 1. Autoantibodies targeting type I interferons: Prevalence, mechanisms of induction, and association with viral disease susceptibility.
    Hale BG
    Eur J Immunol; 2023 Jun; 53(6):e2250164. PubMed ID: 37027328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon autoantibodies as signals of a sick thymus.
    Oftedal BE; Sjøgren T; Wolff ASB
    Front Immunol; 2024; 15():1327784. PubMed ID: 38455040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
    Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
    PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe acute herpes virus type 2 primo-infection and its association with anti-type 1 interferon autoantibodies.
    Martinot M; Gravier S; Mohseni-Zadeh M; Fabien N; Casanova JL; Puel A; Goncalves D
    Eur J Clin Microbiol Infect Dis; 2023 Dec; 42(12):1531-1535. PubMed ID: 37870714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Neutralizing Anti-Type 1 Interferon Autoantibodies.
    Shaw ER; Rosen LB; Ding L; Holland SM; Su HC
    Curr Protoc; 2022 Aug; 2(8):e511. PubMed ID: 35976040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.
    Busnadiego I; Abela IA; Frey PM; Hofmaenner DA; Scheier TC; Schuepbach RA; Buehler PK; Brugger SD; Hale BG
    PLoS Biol; 2022 Jul; 20(7):e3001709. PubMed ID: 35788562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Lymphocyte Immunophenotyping and Quantitative Anti-Interferon Gamma Autoantibodies in Taiwanese HIV-Negative Patients with Non-Tuberculous Mycobacterial Infections.
    Lee WI; Fang YF; Huang JL; You HL; Hsieh MY; Huang WT; Liang CJ; Kang CC; Wu TS
    J Clin Immunol; 2023 May; 43(4):717-727. PubMed ID: 36624329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of interferon in the thymus.
    Martinez RJ; Hogquist KA
    Curr Opin Immunol; 2023 Oct; 84():102389. PubMed ID: 37738858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α.
    Mathian A; Breillat P; Dorgham K; Bastard P; Charre C; Lhote R; Quentric P; Moyon Q; Mariaggi AA; Mouries-Martin S; Mellot C; Anna F; Haroche J; Cohen-Aubart F; Sterlin D; Zahr N; Gervais A; Le Voyer T; Bizien L; Amiot Q; Pha M; Hié M; Chasset F; Yssel H; Miyara M; Charneau P; Ghillani-Dalbin P; Casanova JL; Rozenberg F; Amoura Z; Gorochov G
    Ann Rheum Dis; 2022 Dec; 81(12):1695-1703. PubMed ID: 35973806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains.
    Yasamut U; Thongkum W; Moonmuang S; Sakkhachornphop S; Chaiwarith R; Praparattanapan J; Wipasa J; Chawansuntati K; Supparatpinyo K; Lai E; Tayapiwatana C
    Front Immunol; 2019; 10():1905. PubMed ID: 31474987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon system deficiencies exacerbating severe pandemic virus infections.
    Stertz S; Hale BG
    Trends Microbiol; 2021 Nov; 29(11):973-982. PubMed ID: 33757684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to Interferons in Infectious Diseases.
    Quiros-Roldan E; Sottini A; Signorini SG; Serana F; Tiecco G; Imberti L
    Viruses; 2023 May; 15(5):. PubMed ID: 37243300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with inhibitory and neutralizing auto-antibodies to interferon-γ resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseases.
    Lee WI; Huang JL; Wu TS; Lee MH; Chen IJ; Yu KH; Liu CY; Yang CH; Hsieh MY; Lin YL; Shih YF; Jaing TH; Huang SC; Kuo TT; Ku CL
    Immunobiology; 2013 May; 218(5):762-71. PubMed ID: 23083630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease.
    Lin CH; Chi CY; Shih HP; Ding JY; Lo CC; Wang SY; Kuo CY; Yeh CF; Tu KH; Liu SH; Chen HK; Ho CH; Ho MW; Lee CH; Lai HC; Ku CL
    Nat Med; 2016 Sep; 22(9):994-1001. PubMed ID: 27525523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies.
    Fernbach S; Mair NK; Abela IA; Groen K; Kuratli R; Lork M; Thorball CW; Bernasconi E; Filippidis P; Leuzinger K; Notter J; Rauch A; Hirsch HH; Huber M; Günthard HF; Fellay J; Kouyos RD; Hale BG;
    J Exp Med; 2024 Sep; 221(9):. PubMed ID: 39017930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs.
    Casanova JL; Anderson MS
    J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36719370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 Pneumonia.
    Vanker M; Särekannu K; Fekkar A; Jørgensen SE; Haljasmägi L; Kallaste A; Kisand K; Lember M; Peterson P; Menon M; Hussell T; Knight S; Moore-Stanley J; Bastard P; Zhang SY; Mogensen TH; Philippot Q; Zhang Q; Puel A; Casanova JL; Kisand K
    J Interferon Cytokine Res; 2023 Sep; 43(9):379-393. PubMed ID: 37253131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature.
    Sugrue JA; Bourke NM; O'Farrelly C
    Front Immunol; 2021; 12():757249. PubMed ID: 34917078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.